ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Zero HLA Mismatch Matters in ABO Incompatible Kidney Transplant.

T. Alhamad,1 K. Lentine,2 K. Venkatachalam,1 A. Malone,1 D. Brennan.1

1Washington University in St. Louis, St. Louis
2Saint Louis University, St. Louis

Meeting: 2017 American Transplant Congress

Abstract number: 56

Keywords: HLA matching, Kidney

Session Information

Session Name: Concurrent Session: Kidney Living Donor Evaluation and Recruitment

Session Type: Concurrent Session

Date: Sunday, April 30, 2017

Session Time: 2:30pm-4:00pm

 Presentation Time: 2:54pm-3:06pm

Location: E450a

Transplantation across blood group incompatibilities (ABOi) after preconditioning has emerged as an acceptable option for expanding live donor kidney transplantation (LKDT) to more patients who can benefit compared to dialysis. Data are lacking on the impact of HLA matching on outcomes after ABOi LDKT.

We performed a retrospective analysis of adult (age >18) recipients of ABOi LDKT recorded in the Organ Procurement and Transplantation Network (OPTN) database between 2000 and 2013. ABOi LDKT recipients were categorized into 4 groups according to level of HLA mismatch (HLA MM); 0, 1-3, 4-5, and 6 Associations between HLA MM and posttransplant graft failure and patient death were examined by Cox regression over up to 13 yrs of follow-up.

There were 1,266 ABOi LDKT in the study period. Of these, the distribution of HLA MM was: 0 MM, 7.3%; 1-3 MM, 37.2%; 4-5, 43.2%; 6 MM, 12.32%. Compared to 4-5 HLA MM, recipients with 0 HLA mismatch had a better kidney 10 yr allograft survival [70% vs 49%, adjusted hazard ratio (aHR) 0.52; 95% CI 0.29-0.91]. In contrast, recipients with 1-3 (aHR 0.89; CI 0.69-1.13) and 6 (aHR 0.93; CI 0.64-1.34) HLA MM showed no significant difference in graft survival compared to 4-5 MM. Among recipients of ABOi LDKT, 0 antigen mismatching improves allograft survival compared to 4-5 HLA mismatches. However, in all groups, ABOi LKDT offers an import option to improve survival compared to dialysis.

CITATION INFORMATION: Alhamad T, Lentine K, Venkatachalam K, Malone A, Brennan D. Zero HLA Mismatch Matters in ABO Incompatible Kidney Transplant. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Alhamad T, Lentine K, Venkatachalam K, Malone A, Brennan D. Zero HLA Mismatch Matters in ABO Incompatible Kidney Transplant. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/zero-hla-mismatch-matters-in-abo-incompatible-kidney-transplant/. Accessed May 9, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences